Benzinga | Dec 20, 2021 06:07AM EST

HC Wainwright & Co. Initiates Coverage On BioCardia with Buy Rating, Announces Price Target of $9

HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on BioCardia (NASDAQ:BCDA) with a Buy rating and announces Price Target of $9.